Clinical TrialsSearch results
Number of results: 649
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Recruiting
- Efficacy and safety of Ibuprofen gargle for oral lichen planus: a phase II, open-label, long-term, extension trial.
- oral lichen planus
- Kakei Yasumasa
- 2022-04-22
Recruiting
- Efficacy of Ibuprofen gargle for oral lichen planus: A comparison study.
- oral lichen planus
- Kakei Yasumasa
- 2022-04-22
Recruiting
- Efficacy of anti-VEGF drug on retinopathy of prematurity
- Retinopathy of prematurity
- Ueda Kaori
- 2022-04-01
Recruiting
- Development of a diagnostic method for pancreatic cancer using 13C glucose
- Pancreatic cancer, benign pancreatic diseases, or other gastroenterological cancers
- Tobimatsu Kazutoshi
- 2022-03-25
Recruiting
- HIF_PHi study
- Heart Failure with Renal Anemia
- Minamino Tohru
- 2022-03-18
Recruiting
- A double-blind, placebo-controlled, randomized, dose-escalating, multicenter, Phase 1 study to assess the safety and tolerability of ART-123 in combination with leucovorin/5-fluorouracil/oxaliplatin and bevacizumab in metastatic colorectal cancer patients
- metastatic colorectal cancer
- Uchida Yugo
- 2022-02-01
Recruiting
- FUTURE study
- Unruptured cerebral aneurysm
- Imamura Hirotoshi
- 2022-01-07
Recruiting
- A Randomized Controlled Trial of the Preventive Effect of Haptoglobin Administration on Hemolysis-Related Organ Damage in Patients undergoing Cardiovascular Surgery
- Valvular heart disease,aortic aneurysm,aortic dissection,coronary artery disease
- Hokka Mai
- 2022-01-05
Recruiting
- Efficacy of therapeutic intervention with vedolizumab for ulcerative colitis patients with no or mild symptom and uncontrolled endoscopic activity: A multicenter- non-randomized trial
- ulcerative colitis
- ooi makoto
- 2021-12-28
Other
- A Phase 3 Multinational, Randomized, Double-Blind, Placebo-Controlled Systemic Gene Delivery Study to Evaluate the Safety and Efficacy of SRP-9001 in Patients With Duchenne Muscular Dystrophy (EMBARK)
- Duchenne Muscular Dystrophy
- O Malley Patrick
- 2021-12-25